INVO Fertility
IVF
INVO Fertility (IVF) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$532.00
- EPS estimate
- −$72.00
- EPS surprise
- −638.89%
- Revenue surprise
- +11.24%
- Revenue
- $1.9M
- Revenue estimate
- $1.7M
- Reported
- Aug 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 14, 2025 | −$72.00 | −$532.00 | −638.89% | $1.9M | SEC |
| Q1 2025 | May 20, 2025 | −$72.00 | −$1,503.60 | −1988.33% | $1.6M | SEC |
| Q4 2024 | Apr 30, 2025 | −$420.00 | −$1,084.80 | −158.29% | $1.7M | SEC |
| Q3 2024 | Nov 19, 2024 | −$129.60 | −$604.80 | −366.67% | $1.4M | SEC |
| Q2 2024 | Aug 14, 2024 | −$201.60 | −$892.80 | −342.86% | $1.8M | SEC |
| Q4 2023 | Apr 16, 2024 | −$1,252.80 | $3,588.48 | +386.44% | $3.5M | SEC |
| Q3 2023 | Nov 13, 2023 | −$1,425.60 | −$809.09 | +43.25% | $1.4M | SEC |
| Q2 2023 | Aug 14, 2023 | −$6,048.00 | −$4,406.40 | +27.14% | $712,433.00 | SEC |
| Q1 2023 | May 15, 2023 | −$4,608.00 | −$5,760.00 | −25.00% | $646,707.00 | SEC |
| Q4 2022 | Apr 17, 2023 | −$5,472.00 | −$6,624.00 | −21.05% | $278,142.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$3,456.00 | −$6,048.00 | −75.00% | $450,131.00 | — |
| Q2 2022 | Aug 15, 2022 | −$6,912.00 | −$6,624.00 | +4.17% | $146,135.00 | — |
| Q1 2022 | May 16, 2022 | −$7,200.00 | −$6,624.00 | +8.00% | $275,683.00 | — |
| Q4 2021 | Mar 31, 2022 | −$6,336.00 | $288.00 | +104.55% | $3.0M | — |
| Q3 2021 | Nov 15, 2021 | −$5,760.00 | −$6,912.00 | −20.00% | $218,874.00 | — |
| Q2 2021 | Aug 16, 2021 | −$5,472.00 | −$4,896.00 | +10.53% | $208,472.00 | — |
| Q1 2021 | May 17, 2021 | −$5,040.00 | −$7,200.00 | −42.86% | $684,762.00 | — |
| Q4 2020 | Mar 30, 2021 | −$6,192.00 | −$13,680.00 | −120.93% | $196,786.00 | SEC |
Quarterly revenue
Frequently asked questions
When did INVO Fertility (IVF) last report earnings?
INVO Fertility last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did IVF beat earnings estimates?
No. INVO Fertility reported EPS of −$532.00 for Q2 2025 against a −$72.00 estimate — a 638.89% miss.
How much revenue did IVF report last quarter?
INVO Fertility reported $1.9M in revenue for Q2 2025, against a consensus estimate of $1.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.